Skip to main content
SpringerLink
Log in

Cabergoline

Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: case report

Reactions Weekly volume 1640, page 78 (2017)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Reference

  • Chouchana L, et al. Neurovascular adverse effects following cabergoline administration in puerperal period. Fundamental and Clinical Pharmacology 30 (Suppl. 1): 27-28 abstr. PM1-013, Apr 2016. Available from: URL: http://doi.org/10.1111/fcp.12189 [abstract] - France

Download references

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cabergoline. Reactions Weekly 1640, 78 (2017). https://doi.org/10.1007/s40278-017-26631-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-26631-9

search

Navigation